Maquet Cardiovascular, LLC recalls Heartstring III Proximal Seal System, 3.8 MM. Intravascular anastomosis occluder.
- Recall date
- August 15, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2587-2025
- FDA classification
- Class II
- Brand / firm
- Maquet Cardiovascular, LLC
- Sold / distributed
- Worldwide distribution - US Nationwide and the countries of Australia, Austria, Bahrain, Belgium, Canada, China, Colombia, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Israel, Italy, Japan, Luxembourg, Malaysia, Netherlands, New Zealand, Norway, Poland, Portugal, S…
Why it was recalled
Three failure modes have been identified: failure of the Heartstring Seal to load, failure of the Heartstring Seal to deploy into the aortotomy, and failure of the deployed Heartstring Seal to provide adequate hemostasis.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Heartstring III Proximal Seal System, 3.8 MM. Intravascular anastomosis occluder.
Get recall alerts
Free email alert whenever Maquet Cardiovascular, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Maquet Cardiovascular, LLC